Overview of the Effect of Citrobacter rodentium Infection on Host Metabolism and the Microbiota.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 2 4 2021
Statut: ppublish

Résumé

Citrobacter rodentium is a natural enteric mouse pathogen that models human intestinal diseases, such as pathogenic E. coli infections, ulcerative colitis, and colon cancer. Upon reaching the monolayer of intestinal epithelial cells (IECs) lining the gut, a complex web of interactions between the host, the pathogen, and the microbiota ensues. A number of studies revealed surprisingly rapid changes in IEC bioenergetics upon infection, involving a switch from oxidative phosphorylation to aerobic glycolysis, leading to mucosal oxygenation and subsequent changes in microbiota composition. Microbiome studies have revealed a bloom in Enterobacteriaceae during C. rodentium infection in both resistant (i.e., C57BL/6) and susceptible (i.e., C3H/HeN) strains of mice concomitant with a depletion of butyrate-producing Clostridia. The emerging understanding that dysbiosis of cholesterol metabolism is induced by enteric infection further confirms the pivotal role immunometabolism plays in disease outcome. Inversely, the host and microbiota also impact upon the progression of infection, from the susceptibility of the distal colon to C. rodentium colonization to clearance of the pathogen, both via opsonization from the host adaptive immune system and out competition by the resident microbiota. Further complicating this compendium of interactions, C. rodentium exploits microbiota metabolites to fine-tune virulence gene expression and promote colonization. This chapter summarizes the current knowledge of the myriad of pathogen-host-microbiota interactions that occur during the progression of C. rodentium infection in mice and the broader implications of these findings on our understanding of enteric disease.

Identifiants

pubmed: 33704766
doi: 10.1007/978-1-0716-1339-9_20
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-418

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Références

Mullineaux-Sanders C, Sanchez-Garrido J, Hopkins EGD, Shenoy AR, Barry R, Frankel G (2019) Citrobacter rodentium-host-microbiota interactions: immunity, bioenergetics and metabolism. Nat Rev Microbiol 17(11):701–715. https://doi.org/10.1038/s41579-019-0252-z
doi: 10.1038/s41579-019-0252-z pubmed: 31541196
Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G (2014) Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol 12(9):612–623. https://doi.org/10.1038/nrmicro3315
doi: 10.1038/nrmicro3315 pubmed: 25088150
Crepin VF, Collins JW, Habibzay M, Frankel G (2016) Citrobacter rodentium mouse model of bacterial infection. Nat Protoc 11(10):1851–1876. https://doi.org/10.1038/nprot.2016.100
doi: 10.1038/nprot.2016.100 pubmed: 27606775
Hartland EL, Leong JM (2013) Enteropathogenic and enterohemorrhagic E. coli: ecology, pathogenesis, and evolution. Front Cell Infect Microbiol 3:15. https://doi.org/10.3389/fcimb.2013.00015
doi: 10.3389/fcimb.2013.00015 pubmed: 23641365 pmcid: 3639409
Capaldo CT, Nusrat A (2015) Claudin switching: physiological plasticity of the tight junction. Semin Cell Dev Biol 42:22–29. https://doi.org/10.1016/j.semcdb.2015.04.003
doi: 10.1016/j.semcdb.2015.04.003 pubmed: 25957515
Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10:131. https://doi.org/10.1038/nri2707 . https://www.nature.com/articles/nri2707#supplementary-information
doi: 10.1038/nri2707 pubmed: 20098461
Lotz M, König T, Ménard S, Gütle D, Bogdan C, Hornef MW (2007) Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology 122(3):306–315. https://doi.org/10.1111/j.1365-2567.2007.02639.x
doi: 10.1111/j.1365-2567.2007.02639.x pubmed: 17511808 pmcid: 2266023
Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, Hilgarth RS, Kundu K, Murthy N, Kusters D, Reutelingsperger C, Perretti M, Parkos CA, Neish AS, Nusrat A (2013) Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 123(1):443–454. https://doi.org/10.1172/jci65831
doi: 10.1172/jci65831 pubmed: 23241962
Swanson PA II, Kumar A, Samarin S, Vijay-Kumar M, Kundu K, Murthy N, Hansen J, Nusrat A, Neish AS (2011) Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci U S A 108(21):8803–8808. https://doi.org/10.1073/pnas.1010042108
doi: 10.1073/pnas.1010042108 pubmed: 21555563 pmcid: 3102402
Wong ARC, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL (2011) Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 80:1420–1438. https://doi.org/10.1111/j.1365-2958.2011.07661.x
doi: 10.1111/j.1365-2958.2011.07661.x pubmed: 21488979
Luperchio SA, Schauer DB (2001) Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3(4):333–340. https://doi.org/10.1016/s1286-4579(01)01387-9
doi: 10.1016/s1286-4579(01)01387-9 pubmed: 11334751
Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S (2005) Citrobacter rodentium of mice and man. Cell Microbiol 7:1697–1706. https://doi.org/10.1111/j.1462-5822.2005.00625.x
doi: 10.1111/j.1462-5822.2005.00625.x pubmed: 16309456
Hopkins EGD, Roumeliotis TI, Mullineaux-Sanders C, Choudhary JS, Frankel G (2019) Intestinal epithelial cells and the microbiome undergo swift reprogramming at the inception of colonic Citrobacter rodentium infection. MBio 10(2). https://doi.org/10.1128/mBio.00062-19
Wiles S, Clare S, Harker J, Huett A, Young D, Dougan G (2004) Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6:963–972. https://doi.org/10.1111/j.1462-5822.2004.00414.x
doi: 10.1111/j.1462-5822.2004.00414.x pubmed: 15339271
Wiles S, Pickard KM, Peng K, MacDonald TT, Frankel G (2006) In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 74:5391–5396. https://doi.org/10.1128/IAI.00848-06
doi: 10.1128/IAI.00848-06 pubmed: 16926434 pmcid: 1594854
Wiles S, Dougan G, Frankel G (2005) Emergence of a ‘hyperinfectious’ bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol 7(8):1163–1172. https://doi.org/10.1111/j.1462-5822.2005.00544.x
doi: 10.1111/j.1462-5822.2005.00544.x pubmed: 16008583
Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB (2010) Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 6(5):e1000902
doi: 10.1371/journal.ppat.1000902
Kamada N, Sakamoto K, Seo S-U, Zeng MY, Kim Y-G, Cascalho M, Vallance BA, Puente JL, Núñez G (2015) Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination. Cell Host Microbe 17(5):617–627
doi: 10.1016/j.chom.2015.04.001
Simmons CP, Clare S, Ghaem-Maghami M, Uren TK, Rankin J, Huett A, Goldin R, Lewis DJ, MacDonald TT, Strugnell RA, Frankel G, Dougan G (2003) Central role for B lymphocytes and CD4
doi: 10.1128/iai.71.9.5077-5086.2003 pubmed: 12933850 pmcid: 187366
Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vazquez A, Barba J, Ibarra JA, O’Donnell P, Metalnikov P, Ashman K, Lee S, Goode D, Pawson T, Finlay BB (2004) Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci 101:3597–3602. https://doi.org/10.1073/pnas.0400326101
doi: 10.1073/pnas.0400326101 pubmed: 14988506
Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, Younis R, Matthews S, Marches O, Frankel G, Hayashi T, Pallen MJ (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci 103:14941–14946. https://doi.org/10.1073/pnas.0604891103
doi: 10.1073/pnas.0604891103 pubmed: 16990433
Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662–671
doi: 10.1016/j.chom.2015.03.005
Espey MG (2013) Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic Biol Med 55:130–140
doi: 10.1016/j.freeradbiomed.2012.10.554
Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Bachash M, Yu L (2017) Citrobacter rodentium subverts ATP flux and cholesterol homeostasis in intestinal epithelial cells in vivo. Cell Metab 26(5):738–752.e736. https://doi.org/10.1016/j.cmet.2017.09.003
doi: 10.1016/j.cmet.2017.09.003 pubmed: 28988824 pmcid: 5695859
Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Bachash M, Yu L, Clements A, Collins JW, Elinav E, Larrouy-Maumus GJ, Choudhary JS, Frankel G (2017) Citrobacter rodentium subverts ATP flux and cholesterol homeostasis in intestinal epithelial cells in vivo. Cell Metab 26(5):738–752.e736. https://doi.org/10.1016/j.cmet.2017.09.003
doi: 10.1016/j.cmet.2017.09.003 pubmed: 28988824 pmcid: 5695859
Ma C, Wickham ME, Guttman JA, Deng W, Walker J, Madsen KL, Jacobson K, Vogl WA, Finlay BB, Vallance BA (2006) Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol 8(10):1669–1686
doi: 10.1111/j.1462-5822.2006.00741.x
Wallimann T, Tokarska-Schlattner M, Schlattner U (2011) The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40(5):1271–1296
doi: 10.1007/s00726-011-0877-3
Vallance BA, Deng W, De Grado M, Chan C, Jacobson K, Finlay BB (2002) Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect Immun 70(11):6424–6435
doi: 10.1128/IAI.70.11.6424-6435.2002
Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P (2003) Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 278(12):10443–10449. https://doi.org/10.1074/jbc.M213071200
doi: 10.1074/jbc.M213071200 pubmed: 12531895
Raczynski AR, Muthupalani S, Schlieper K, Fox JG, Tannenbaum SR, Schauer DB (2012) Enteric infection with Citrobacter rodentium induces coagulative liver necrosis and hepatic inflammation prior to peak infection and colonic disease. PLoS One 7(3):e33099. https://doi.org/10.1371/journal.pone.0033099
doi: 10.1371/journal.pone.0033099 pubmed: 22427959 pmcid: 3302869
Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Dori-Bachash M, Yu L, Clements A, Collins JW, Elinav E, Larrouy-Maumus GJ, Choudhary JS, Frankel G (2017) Citrobacter rodentium subverts ATP flux and cholesterol homeostasis in intestinal epithelial cells in vivo. Cell Metab 26(5):738–752.e736. https://doi.org/10.1016/j.cmet.2017.09.003
doi: 10.1016/j.cmet.2017.09.003 pubmed: 28988824 pmcid: 5695859
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485–498
doi: 10.1016/j.cell.2009.09.033
Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB (2011) Altering host resistance to infections through microbial transplantation. PLoS One 6:2–10. https://doi.org/10.1371/journal.pone.0026988
doi: 10.1371/journal.pone.0026988
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620–625. https://doi.org/10.1038/nature07008
doi: 10.1038/nature07008 pubmed: 18509436
Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204–12209. https://doi.org/10.1073/pnas.0909122107
doi: 10.1073/pnas.0909122107 pubmed: 20566854 pmcid: 2901479
Caballero-Franco C, Keller K, De Simone C, Chadee K (2007) The VSL# 3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292(1):G315–G322
doi: 10.1152/ajpgi.00265.2006
Burger-van Paassen N, Vincent A, Puiman PJ, Van Der Sluis M, Bouma J, Boehm G, Van Goudoever JB, Van Seuningen I, Renes IB (2009) The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 420(2):211–219
doi: 10.1042/BJ20082222
Wrzosek L, Miquel S, Noordine M-L, Bouet S, Chevalier-Curt MJ, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C (2013) Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol 11(1):61
doi: 10.1186/1741-7007-11-61
Roediger W (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83(2):424–429
doi: 10.1016/S0016-5085(82)80339-9
Millette M, Cornut G, Dupont C, Shareck F, Archambault D, Lacroix M (2008) Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci. Appl Environ Microbiol 74(7):1997–2003. https://doi.org/10.1128/aem.02150-07
doi: 10.1128/aem.02150-07 pubmed: 18245231 pmcid: 2292579
Stecher B, Hardt W-D (2010) Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 14:82–91. https://doi.org/10.1016/j.mib.2010.10.003
doi: 10.1016/j.mib.2010.10.003 pubmed: 21036098
Stelter C, Käppeli R, König C, Krah A, Hardt W-D, Stecher B, Bumann D (2011) Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. PLoS One 6(6):e20749. https://doi.org/10.1371/journal.pone.0020749
doi: 10.1371/journal.pone.0020749 pubmed: 21694778 pmcid: 3111430
Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, Sterzenbach T, Tsolis RM, Roth JR, Bäumler AJ (2011) Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci 108(42):17480–17485. https://doi.org/10.1073/pnas.1107857108
doi: 10.1073/pnas.1107857108 pubmed: 21969563
Le Blay G, Rytka J, Zihler A, Lacroix C (2009) New in vitro colonic fermentation model for Salmonella infection in the child gut. FEMS Microbiol Ecol 67(2):198–207. https://doi.org/10.1111/j.1574-6941.2008.00625.x
doi: 10.1111/j.1574-6941.2008.00625.x pubmed: 19087202
Kamada N, Kim Y-G, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G (2012) Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 338:643–646
doi: 10.1126/science.1228604
Fabich AJ, Jones SA, Chowdhury FZ, Cernosek A, Anderson A, Smalley D, McHargue JW, Hightower GA, Smith JT, Autieri SM (2008) Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun 76(3):1143–1152
doi: 10.1128/IAI.01386-07
Levy M, Thaiss CA, Zeevi D, Dohnalova L, Zilberman-Schapira G, Mahdi JA, David E, Savidor A, Korem T, Herzig Y, Pevsner-Fischer M, Shapiro H, Christ A, Harmelin A, Halpern Z, Latz E, Flavell RA, Amit I, Segal E, Elinav E (2015) Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163(6):1428–1443. https://doi.org/10.1016/j.cell.2015.10.048
doi: 10.1016/j.cell.2015.10.048 pubmed: 26638072 pmcid: 5665753
Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV (2008) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 105(52):20858–20863. https://doi.org/10.1073/pnas.0808723105
doi: 10.1073/pnas.0808723105 pubmed: 19075245 pmcid: 2603261
Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, Flavell RA (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307(5710):731–734. https://doi.org/10.1126/science.1104911
doi: 10.1126/science.1104911 pubmed: 15692051
Mullineaux-Sanders C, Collins JW, Ruano-Gallego D, Levy M, Pevsner-Fischer M, Glegola-Madejska IT, Sågfors AM, Wong JLC, Elinav E, Crepin VF, Frankel G (2017) Citrobacter rodentium relies on commensals for colonization of the colonic mucosa. Cell Rep 21:3381–3389. https://doi.org/10.1016/j.celrep.2017.11.086
doi: 10.1016/j.celrep.2017.11.086 pubmed: 29262319 pmcid: 5746604
Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5(2):220–230. https://doi.org/10.1038/ismej.2010.118
doi: 10.1038/ismej.2010.118 pubmed: 20686513
Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14. https://doi.org/10.1126/scitranslmed.3000322
doi: 10.1126/scitranslmed.3000322 pubmed: 20368178 pmcid: 2894525
Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, Ma C, Halder S, Montero M, Ionescu V-A (2011) Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol 301(1):G39–G49
doi: 10.1152/ajpgi.00509.2010
Smith AD, Botero S, Shea-Donohue T, Urban JF (2011) The pathogenicity of an enteric Citrobacter rodentium infection is enhanced by deficiencies in the antioxidants selenium and vitamin E. Infect Immun 79(4):1471–1478
doi: 10.1128/IAI.01017-10
Ryz NR, Lochner A, Bhullar K, Ma C, Huang T, Bhinder G, Bosman E, Wu X, Innis SM, Jacobson K (2015) Dietary Vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium induced colitis. Am J Phys Heart Circ Phys 309:G730
Metidji A, Omenetti S, Crotta S, Li Y, Nye E, Ross E, Li V, Maradana MR, Schiering C, Stockinger B (2018) The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity 49:353–362.e355. https://doi.org/10.1016/j.immuni.2018.07.010
doi: 10.1016/j.immuni.2018.07.010 pubmed: 30119997 pmcid: 6104739
Ghosh S, DeCoffe D, Brown K, Rajendiran E, Estaki M, Dai C, Yip A, Gibson DL (2013) Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 8(2):e55468
doi: 10.1371/journal.pone.0055468
Joshi S, Pantalena L-C, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, Ichiyama K, Yoshimura A, Steinman L, Christakos S (2011) 1, 25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 31(17):3653–3669
doi: 10.1128/MCB.05020-11
Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM, Weaver CT (2011) Lineage-specific effects of 1, 25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J Biol Chem 286(2):997–1004
doi: 10.1074/jbc.M110.163790
Mangan PR, Harrington LE, O’quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Transforming growth factor-β induces development of the T H 17 lineage. Nature 441(7090):231
doi: 10.1038/nature04754
Cantorna MT (2010) Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 69(3):286–289
doi: 10.1017/S0029665110001722
Lopez CA, Miller BM, Rivera-Chávez F, Velazquez EM, Byndloss MX, Chávez-Arroyo A, Lokken KL, Tsolis RM, Winter SE, Bäumler AJ (2016) Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration. Science 353(6305):1249–1253
doi: 10.1126/science.aag3042
Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V (2012) Fucose sensing regulates bacterial intestinal colonization. Nature 492(7427):113–117
doi: 10.1038/nature11623
Kumar A, Sperandio V (2019) Indole signaling at the host-microbiota-pathogen interface. MBio 10(3):e01031–e01019. https://doi.org/10.1128/mBio.01031-19
doi: 10.1128/mBio.01031-19 pubmed: 31164470 pmcid: 6550529
Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V (2014) The gut commensal bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16:759–769. https://doi.org/10.1016/j.chom.2014.11.005
doi: 10.1016/j.chom.2014.11.005 pubmed: 25498343 pmcid: 4269104
Connolly JP, Slater SL, O’Boyle N, Goldstone RJ, Crepin VF, Gallego DR, Herzyk P, Smith DG, Douce GR, Frankel G (2018) Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion. Nat Commun 9(1):4187
doi: 10.1038/s41467-018-06701-4
Cameron EA, Curtis MM, Kumar A, Dunny GM, Sperandio V (2018) Microbiota and pathogen proteases modulate type III secretion activity in enterohemorrhagic Escherichia coli. MBio 9(6):e02204–e02218
doi: 10.1128/mBio.02204-18
Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, Dematteo RP, Pamer EG (2008) Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804–807. https://doi.org/10.1038/nature07250
doi: 10.1038/nature07250 pubmed: 18724361 pmcid: 2663337
Ivanov II, Frutos RL, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349. https://doi.org/10.1016/j.chom.2008.09.009
doi: 10.1016/j.chom.2008.09.009 pubmed: 18854238 pmcid: 2597589
Lebeis SL, Bommarius B, Parkos CA, Sherman MA, Kalman D (2007) TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J Immunol 179(1):566–577. https://doi.org/10.4049/jimmunol.179.1.566
doi: 10.4049/jimmunol.179.1.566 pubmed: 17579078
Barry R, Ruano-Gallego D, Radhakrishnan ST, Lovell S, Yu L, Kotik O, Glegola-Madejska I, Tate EW, Choudhary JS, Williams HRT, Frankel G (2020) Faecal neutrophil elastase-antiprotease balance reflects colitis severity. Mucosal Immunol 13:322. https://doi.org/10.1038/s41385-019-0235-4
doi: 10.1038/s41385-019-0235-4 pubmed: 31772324
Muñoz M, Eidenschenk C, Ota N, Wong K, Lohmann U, Kühl AA, Wang X, Manzanillo P, Li Y, Rutz S (2015) Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42(2):321–331
doi: 10.1016/j.immuni.2015.01.011
Rutz S, Eidenschenk C, Ouyang W (2013) IL-22, not simply a Th17 cytokine. Immunol Rev 252(1):116–132. https://doi.org/10.1111/imr.12027
doi: 10.1111/imr.12027 pubmed: 23405899
Zenewicz LA, Flavell RA (2011) Recent advances in IL-22 biology. Int Immunol 23(3):159–163. https://doi.org/10.1093/intimm/dxr001
doi: 10.1093/intimm/dxr001 pubmed: 21393631
Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36(5):1309–1323. https://doi.org/10.1002/eji.200535503
doi: 10.1002/eji.200535503 pubmed: 16619290
Tsai PY, Zhang B, He WQ, Zha JM, Odenwald MA, Singh G, Tamura A, Shen L, Sailer A, Yeruva S, Kuo WT, Fu YX, Tsukita S, Turner JR (2017) IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance. Cell Host Microbe 21:671–681.e674. https://doi.org/10.1016/j.chom.2017.05.009
doi: 10.1016/j.chom.2017.05.009 pubmed: 28618266 pmcid: 5541253
Lee Y-S, Yang H, Yang J-Y, Kim Y, Lee S-H, Kim JH, Jang YJ, Vallance BA, Kweon M-N (2015) Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/CXCL1 secretion, which correlates with recruitment of IL-22-secreting neutrophils at early stages of Citrobacter rodentium infection. Infect Immun 83(8):3257–3267
doi: 10.1128/IAI.00670-15
Backert I, Koralov SB, Wirtz S, Kitowski V, Billmeier U, Martini E, Hofmann K, Hildner K, Wittkopf N, Brecht K (2014) STAT3 activation in Th17 and Th22 cells controls IL-22–mediated epithelial host defense during infectious colitis. J Immunol 193(7):3779–3791
doi: 10.4049/jimmunol.1303076
Guo X, Qiu J, Tu T, Yang X, Deng L, Anders RA, Zhou L, Fu Y-X (2014) Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40(1):25–39
doi: 10.1016/j.immuni.2013.10.021
Pham TAN, Clare S, Goulding D, Arasteh JM, Stares MD, Browne HP, Keane JA, Page AJ, Kumasaka N, Kane L, Mottram L, Harcourt K, Hale C, Arends MJ, Gaffney DJ, Dougan G, Lawley TD (2014) Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16:504–516. https://doi.org/10.1016/j.chom.2014.08.017
doi: 10.1016/j.chom.2014.08.017 pubmed: 25263220 pmcid: 25263220
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, De Sauvage FJ, Ouyang W (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289. https://doi.org/10.1038/nm1720
doi: 10.1038/nm1720 pubmed: 18264109
Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Serafini N, Pevsner-Fischer M, Yu L, Elinav E, Di Santo JP, Choudhary JS (2018) The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses. PLoS Pathog 14(10):e1007406
doi: 10.1371/journal.ppat.1007406
Basu R, O’Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, Hatton RD, Weaver CT (2012) Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37(6):1061–1075. https://doi.org/10.1016/j.immuni.2012.08.024
doi: 10.1016/j.immuni.2012.08.024 pubmed: 23200827 pmcid: 3678257
Kruglov AA, Lampropoulou V, Fillatreau S, Nedospasov SA (2011) Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells. J Immunol 187(11):5660–5670. https://doi.org/10.4049/jimmunol.1100663
doi: 10.4049/jimmunol.1100663 pubmed: 22058414
Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157:121–141. https://doi.org/10.1016/j.cell.2014.03.011
doi: 10.1016/j.cell.2014.03.011 pubmed: 24679531 pmcid: 4056765
Macho-Fernandez E, Brigl M (2015) The extended family of CD1d-restricted NKT cells: sifting through a mixed bag of TCRs, antigens, and functions. Front Immunol 6:362. https://doi.org/10.3389/fimmu.2015.00362
doi: 10.3389/fimmu.2015.00362 pubmed: 26284062 pmcid: 4517383
Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Serafini N, Pevsner-Fischer M, Yu L, Elinav E, Di Santo JP, Choudhary JS, Frankel G (2018) The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses. PLoS Pathog 14:e1007406. https://doi.org/10.1371/journal.ppat.1007406
doi: 10.1371/journal.ppat.1007406 pubmed: 30365535 pmcid: 6221368
Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL (2016) Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 388(10051):1291–1301
doi: 10.1016/S0140-6736(16)31529-X
Papapietro O, Teatero S, Thanabalasuriar A, Yuki KE, Diez E, Zhu L, Kang E, Dhillon S, Muise AM, Durocher Y (2013) R-spondin 2 signalling mediates susceptibility to fatal infectious diarrhoea. Nat Commun 4:1898
doi: 10.1038/ncomms2816
Carson D, Barry R, Hopkins EGD, Roumeliotis TI, Garcia-Weber D, Mullineaux-Sanders C, Elinav E, Arrieumerlou C, Choudhary JS, Frankel G (2020) Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease. Cell Microbiol 22(1):e13126. https://doi.org/10.1111/cmi.13126
doi: 10.1111/cmi.13126 pubmed: 31610608
Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O’Connell RM, Cheng G, Saez E (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119(2):299–309
doi: 10.1016/j.cell.2004.09.032
Korf H, Vander Beken S, Romano M, Steffensen KR, Stijlemans B, Gustafsson J-Å, Grooten J, Huygen K (2009) Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest 119(6):1626–1637
doi: 10.1172/JCI35288
Smoak K, Madenspacher J, Jeyaseelan S, Williams B, Dixon D, Poch KR, Nick JA, Worthen GS, Fessler MB (2008) Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol 180(5):3305–3312
doi: 10.4049/jimmunol.180.5.3305
McDaniel KL, Restori KH, Dodds JW, Kennett MJ, Ross AC, Cantorna MT (2015) Vitamin A-deficient hosts become nonsymptomatic reservoirs of Escherichia coli-like enteric infections. Infect Immun 83(7):2984–2991
doi: 10.1128/IAI.00201-15
Sanchez KK, Chen GY, Schieber AMP, Redford SE, Shokhirev MN, Leblanc M, Lee YM, Ayres JS (2018) Cooperative metabolic adaptations in the host can favor asymptomatic infection and select for attenuated virulence in an enteric pathogen. Cell 175(1):146–158. e115
doi: 10.1016/j.cell.2018.07.016
Gillis CC, Hughes ER, Spiga L, Winter MG, Zhu W, de Carvalho TF, Chanin RB, Behrendt CL, Hooper LV, Santos RL (2018) Dysbiosis-associated change in host metabolism generates lactate to support Salmonella growth. Cell Host Microbe 23:54
doi: 10.1016/j.chom.2017.11.006
Stappenbeck TS, Virgin HW (2016) Accounting for reciprocal host–microbiome interactions in experimental science. Nature 534(7606):191
doi: 10.1038/nature18285
Fricker AM, Podlesny D, Fricke WF (2019) What is new and relevant for sequencing-based microbiome research? A mini-review. J Adv Res 19:105–112. https://doi.org/10.1016/j.jare.2019.03.006
doi: 10.1016/j.jare.2019.03.006 pubmed: 31341676 pmcid: 6630040

Auteurs

Eve G D Hopkins (EGD)

MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, UK.

Gad Frankel (G)

MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, UK. g.frankel@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH